The European Movianto Group and the Portugal based Rangel Logistics Solutions have entered into a cooperation for international pharmaceutical logistics solutions. “To implement our approach for dedicated logistics solutions throughout Europe we had to take the decision to build up our own network in Portugal or to rely on a proven partner in the country who fulfils our quality standards,” says Thomas Creuzberger, CEO of Movianto. “Through the recently signed cooperation agreement we save time to market, as we can offer solutions integrating the Portuguese market much quicker than with building an own organisation.” In Portugal distribution of most of the medical goods is bound to storing them in a warehouse in the country. “Therefore nobody is able to organise this for example out of Spain. You are obliged to have warehousing and distribution capacity according to the GDP-standards for the Pharma- and Healthcare industries in Portugal itself.”
Rangel has started this network in 2009 in Portugal and developed to be the national market leader for this industry. The company provides a storage infrastructure for pharma and healthcare products that require storage conditions between 15ºC and 25ºC, 2ºC to 8ºC, also for psychotropic, clinical trials, and products for veterinary use. A nationwide cold chain transport network with active temperature control at 2° to 8° Celsius distributes medicines and pharmaceuticals which are stored in one of the dedicated pharmaceutical warehouses of Rangel in the country. “Through the cooperation agreement both companies not only expand their geographical coverage, but get the possibility to take part in the growing number of tenders, where it is a prerequisite to offer a service across national borders,” says Nuno Rangel, Vice President and CEO of Rangel.
Comments are closed.